Fair Value Calculator Fair Value Calculator
EN DE

1217 (1217) Fair Value & Analysis

Financial Services · Market cap HK$141M

1 1217 1217 · HK
PriceHK$0.0100
Fair ValueHK$0.0107
Upside+6.5%
Quality48/100
Evidence: Medium Range HK$0.0102 – HK$0.0109

Fair value as of: Jul 2, 2026

From 14 valuation models · updated today

Share price −9.1% over the past month.

Price vs Fair Value (12 months)

HK$0.0170 HK$0.0100 Fair Value HK$0.0107 Jun 2025 Jun 2026

12‑month range HK$0.0100 – HK$0.0170 · fair‑value band HK$0.0102 – HK$0.0109 · the HK$0.0100 price screens below the HK$0.0107 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1217 (1217) currently trades at HK$0.0100, while our model-based Fair Value estimate is HK$0.0107 — implying the stock looks roughly 6.5% undervalued today. We read business quality at 48/100 (below-average quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 1217 generated revenue of HK$69.7M at a net margin of 81.3%. It earns a return on equity of 9.9%. The balance sheet holds a net cash position of HK$139M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$69.7M
Revenue growth (YoY) +362%
Net margin 81.3%
Return on equity 9.9%
Free cash flow −HK$29.6M FY2025
Operating margin 87.2%
More key figures
EPS growth (YoY) +185%
Net cash HK$139M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1217 reported revenue of HK$64.6M in FY2025 versus −HK$26.7M in FY2021. Reported net income was HK$56.7M in FY2025.

Revenue
FY21 −HK$26.7M
FY22 HK$34.4M
FY23 HK$3.1M
FY24 HK$20.3M
FY25 HK$64.6M
Net income
FY21 −HK$33.9M
FY22 HK$5.8M
FY23 HK$2.2M
FY24 HK$5.0M
FY25 HK$56.7M

Is 1217 fairly valued? → Check now

Similar stocks

6 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $4.20 $6.41 +53%
The Schiehallion Fund Limited MNTN $2.27 $4.54 +100%
BLK BLK 17,417 MXN 10,294 MXN -41%
BlackRock, Inc UU2 €907.20 €544.03 -40%
BH Macro Limited BHMU $0.0442 $0.0900 +104%
Blackstone Inc BX $118.55 $61.04 -49%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1217 (1217) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.0107 versus a price of HK$0.0100 — about +7% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 1217?
Our model-based fair value for 1217 is HK$0.0107 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0100.
What is the quality score of 1217?
1217 has a Quality Score of 48/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1217 (1217)?
1217 reported trailing-twelve-month revenue of about HK$69.7M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1217?
The net profit margin of 1217 is about 81.3%, meaning it keeps roughly 81.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.